Altimmune, Inc.

ALT · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$61,236$183,105$49,104$36,926
Short-Term Investments$149,540$0$100,722$94,965
Receivables$145$878$2,464$3,117
Inventory$0$0$0$0
Other Curr. Assets$5,694$4,439$2,972$2,246
Total Curr. Assets$216,615$188,422$155,262$137,254
Property Plant & Equip (Net)$1,832$364$384$413
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$1,564$1,617$1,639
Total NC Assets$1,832$1,928$2,001$2,052
Other Assets$0$0$0$0
Total Assets$218,447$190,350$157,263$139,306
Liabilities
Payables$4,804$851$1,077$211
Short-Term Debt$247$239$245$279
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$7,555$8,130$8,476$9,978
Total Curr. Liab.$12,606$9,220$9,798$10,468
LT Debt$15,658$15,610$1,342$1,402
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$4,582$4,153$3,961$3,928
Total NC Liab.$20,240$19,763$5,303$5,330
Other Liabilities$0$0$0$0
Cap. Leases$1,460$1,517$1,587$1,681
Total Liabilities$32,846$28,983$15,101$15,798
Equity
Pref Stock$0$0$0$0
Common Stock$10$9$8$7
Retained Earnings-$622,125-$603,111-$580,965-$561,390
AOCI-$5,016-$5,039-$5,003-$4,973
Other Equity$812,732$769,508$728,122$689,864
Total Equity$185,601$161,367$142,162$123,508
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$218,447$190,350$157,263$139,306
Net Debt-$45,331-$167,256-$47,517-$35,245